Ad
related to: traveler's diarrhea pre consultation test printable paper
Search results
Results From The WOW.Com Content Network
Travelers' diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. [ 2 ] [ 3 ] It may be accompanied by abdominal cramps, nausea, fever, headache and bloating. [ 3 ]
Enterotoxigenic Escherichia coli (ETEC) is a type of Escherichia coli and one of the leading bacterial causes of diarrhea in the developing world, [1] as well as the most common cause of travelers' diarrhea. [2] Insufficient data exists, but conservative estimates suggest that each year, about 157,000 deaths occur, mostly in children, from ETEC.
Enterotoxigenic E. coli (ETEC) produces a toxin that acts on the intestinal lining, and is the most common cause of traveler's diarrhea. Enteropathogenic E. coli (EPEC) can cause diarrhea outbreaks in newborn nurseries. Enteroaggregative E. coli (EAggEC) can cause acute and chronic (long-lasting) diarrhea in children.
And what causes diarrhea? While many different things can cause diarrhea—including infections or a more serious gastrointestinal condition—in most cases, it will go away after a few days ...
Various studies have sought to estimate diarrhea attack rates among wilderness travelers, and results have ranged widely. The variation of diarrhea rate between studies may depend on the time of year, the location of the study, the length of time the hikers were in the wilderness, [2] [34] the prevention methods used, and the study methodology.
E.coli causes intestinal infections, some intestinal infections include diarrhea, fever and abdominal pain. Most severe cases can lead to bloody diarrhea, dehydration or even kidney failure. People with weakened immune systems, young children, older adults and pregnant women are at increased risks for developing these complications.
Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...
Areas of research included malaria, vaccines and travelers’ diarrhea. [7] [8] [9] He conducted a study on the oral antibiotic formulation Rifamycin SV – MMX for treating traveler’s diarrhea and also promoted researches on the interests of older travelers. [10] [11] Lately he focused on a viral infection called Tick-borne encephalitis (TBE ...